September 29th /2016
L.O.M. Medical International Inc. and L.O.M. Laboratories Inc. is pleased to invite you to a corporate shareholder update/information meeting. Corporate Information meetings are being held due to the progress L.O.M. has achieved, the importance that all shareholders have access to current information and the opportunity to participate in the “Rights Offering”. It is an opportunity for you and interested investors to personally receive a corporate update and see a demonstration of the L.O.M. 3 ml retractable safety syringe that will soon be in production.
Presentors – Herbert Towning, president/CEO, Ralph Woloschuk, vice president/CTO of L.O.M and Jeremy Webster, with Deloitte Life Sciences Division.
R.V.S.P. by email to email@example.com or call Debbie Ulansky at 604-616-6265
PRESTIGEE HOTEL KELOWNA
1675 Abbott St, Kelowna, BC V1Y 8S3
October 12th 5:30pm to 7:30pm
AGENDA – PRESENTATIONS
Summary of L.O.M.
History of the business
Regulatory and clinical Leadership
Near term milestones
Questions & Discussion